Agreements reached under this partnership
Business Alliances- 1
Conduct technical studies on the culture of umbilical cord-derived mesenchymal stromal cells and extracellular vesicles
- 2
Share necessary information and know-how
- 3
Work to establish an organisational framework for business development
These are items that the documents state the two companies will work on. The lines above and below represent arrangements between the two companies.
The impact of this matter on our financial results is expected to be immaterial.
| Item | Details |
|---|---|
| Name of alliance partner | StemCell Institute |
| Alliance partner's business activities | The company operates a cell banking business involving cells derived from perinatal tissues, including umbilical cords and cord blood, for regenerative medicine and cell therapy, leveraging its strong network of obstetrics and gynecology facilities. It also develops new treatments in the regenerative medicine and cell therapy fields, and engages in business development and investment in related areas. |
| Alliance partner's location | Minato-ku, Tokyo |
| Alliance partner's capital | ¥704.8 million |
| Type of alliance | Business Alliances |
| Details of the alliance | Conduct technical studies on the culture of umbilical cord-derived mesenchymal stromal cells and extracellular vesicles, Share necessary information and know-how, Work to establish an organisational framework for business development |
| Impact on Business Performance | The impact of this matter on our financial results is expected to be immaterial. |
Items this document does not state (16)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To combine StemCell Institute's technologies and expertise in processing and storing umbilical cords and cord blood with CellSource's technologies and expertise in cell processing, quality control and extracellular vesicles.